Dynavax Technologies Corp

NASDAQ: DVAX
$11.76
-$0.08 (-0.7%)
Closing price April 23, 2024
Dynavax Technologies Corp is a biopharmaceutical company based in Emeryville, California, specializing in the development and commercialization of vaccines. Its flagship product is HEPLISAV-B, a hepatitis B vaccine designed for adults, which is available in the United States and Europe. The company also produces CpG 1018, a key ingredient in HEPLISAV-B. Dynavax collaborates with several global partners to expand its vaccine offerings and improve public health outcomes.
Dynavax Technologies Corp. (NASDAQ: DVAX) shares  crumbled Monday morning after the company said that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA)....
September 2, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Friday’s session. NYSE advancers led decliners by nearly 4 to 1 and...
24/7 Wall St. has collected a few more U.S. Food and Drug Administration (FDA) decisions coming up in March.
March 9, 2016: Here are four stocks trading with heavy volume among 26 equities making new 52-week lows in Wednesday’s session. Unisys Corp. (NYSE: UIS) fell by nearly 28% on Wednesday to post...
Dynavax Technologies led the bulls on Thursday with positive results from a late stage clinical trial, on another consecutive down day for the broad markets.
Monday's top analyst upgrades and downgrades include AK Steel, Carnival, EMC, Kinder Morgan, NVIDIA, Staples and Tyco International.
Here are the four top biotech names we found that all have hepatitis C drugs in their current pipelines at one stage or another and that could be the next takeover targets.
Source: ThinkstockWith the top stocks in the market exploding in price due to the recent rally, we wanted to scan across our research universe for some lower priced names that could have significant...
January was a month that short sellers have been dreaming of. Here are top six names that saw the highest percentage of short covering.
Here are some of the top biotech names to buy at Cowen. They presented such an extensive list that we focused on the quality large cap names and the stocks with the highest upside to their target...
U.S. equity markets opened lower this morning, but gathered steam following encouraging reports on new claims for jobless benefits (down) and retail sales (up). There was little economic data from...
U.S. equity markets opened higher this morning following some mixed economic data released in China. The country’s CPI rose less than expected, producer prices fell, fixed asset investment rose a...
Source: ThinkstockDynavax Technologies Corp. (NASDAQ: DVAX) was a small cap stock even before today’s news, but a complete response letter from U.S. Food and Drug Administration (FDA) has taken...
The stock market is mixed Monday, with the Dow Jones Industrial Average down 0.08%, the Nasdaq up 0.17% and the S&P 500 down 0.01%. Today’s winners are an online gaming firm that may benefit from...
Source: ThinkstockDynavax Technologies Corp. (NASDAQ: DVAX) is feeling the wrath of the markets after an FDA panel said that there was insufficient data to support its investigational Hepatitis B...